These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8360812)

  • 21. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model.
    Zarif L; Graybill JR; Perlin D; Najvar L; Bocanegra R; Mannino RJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1463-9. PubMed ID: 10817694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2003 Sep; 52(3):412-8. PubMed ID: 12917237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of experimental murine candidiasis with liposome-associated amphotericin B.
    Ahrens J; Graybill JR; Craven PC; Taylor RL
    Sabouraudia; 1984; 22(2):163-6. PubMed ID: 6729660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.
    Grisin T; Bories C; Bombardi M; Loiseau PM; Rouffiac V; Solgadi A; Mallet JM; Ponchel G; Bouchemal K
    Pharm Res; 2017 May; 34(5):1067-1082. PubMed ID: 28168390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.
    Burgess BL; He Y; Baker MM; Luo B; Carroll SF; Forte TM; Oda MN
    Int J Nanomedicine; 2013; 8():4733-43. PubMed ID: 24379661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel biodegradable poly(gamma-glutamic acid)-amphotericin B complexes show promise as improved amphotericin B formulations.
    Dinh T; Zia Q; Zubair S; Stapleton P; Singh R; Owais M; Somavarapu S
    Nanomedicine; 2017 Jul; 13(5):1773-1783. PubMed ID: 28216150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of antifungal pharmacodynamic characteristics of AmBisome against Candida albicans.
    Takemoto K; Yamamoto Y; Ueda Y
    Microbiol Immunol; 2006; 50(8):579-86. PubMed ID: 16924142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of experimental murine candidiasis with liposome-encapsulated amphotericin B].
    Sasahara T
    Kansenshogaku Zasshi; 1989 Dec; 63(12):1301-7. PubMed ID: 2621383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.
    Caillot D; Casasnovas O; Solary E; Chavanet P; Bonnotte B; Reny G; Entezam F; Lopez J; Bonnin A; Guy H
    J Antimicrob Chemother; 1993 Jan; 31(1):161-9. PubMed ID: 8444659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model.
    Takemoto K; Yamamoto Y; Kanazawa K
    J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
    Morrison CJ; Stevens DA
    Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
    Fukui H; Koike T; Nakagawa T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Nov; 267(1-2):101-12. PubMed ID: 14602388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.
    Saint-Julien L; Joly V; Seman M; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2722-8. PubMed ID: 1482139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
    Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
    J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation.
    Alvarez C; Andes DR; Kang JY; Krug C; Kwon GS
    Pharm Res; 2017 May; 34(5):1115-1124. PubMed ID: 28205003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.
    Chavanet PY; Garry I; Charlier N; Caillot D; Kisterman JP; D'Athis M; Portier H
    BMJ; 1992 Oct; 305(6859):921-5. PubMed ID: 1458072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity, reduced toxicity, and scale-up synthesis of amphotericin B-conjugated polysaccharide.
    Ickowicz DE; Farber S; Sionov E; Kagan S; Hoffman A; Polacheck I; Domb AJ
    Biomacromolecules; 2014 Jun; 15(6):2079-89. PubMed ID: 24779556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel injectable water-soluble amphotericin B-arabinogalactan conjugate.
    Falk R; Domb AJ; Polacheck I
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1975-81. PubMed ID: 10428922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.